Our results are in line with previous reports showing the slower growth of estrogen receptor-negative breast cancers with high PSMB9 expression26 and another one demonstrating that increased ImP gene expression is associated with longer survival for breast cancer patients25. This evidence concerns the gene ESR1 and breast carcinoma.